H100 Group (H100) H2 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
H2 23/24 earnings summary
13 Jun, 2025Executive summary
Net sales for the year were SEK 1,510,872, down from SEK 2,445,578 year-over-year, reflecting lower trading activity and no major portfolio exits.
EBIT loss widened to SEK -6,024,229 from SEK -3,636,455, mainly due to realized losses in the securities portfolio.
Result after financial items was SEK -9,767,786, compared to SEK -5,885,452, impacted by SEK -3,762,894 in unrealized write-downs.
Substantial portfolio revaluations: Hello There Games written down by SEK 5.6m, Evendo Ltd written up by SEK 3.3m.
CEO contract terminated in April 2024; strategic review ongoing to optimize shareholder value.
Financial highlights
Net sales for H2 were SEK 881,659, up from SEK 606,373 year-over-year.
EBIT for H2 was SEK -4,024,383, compared to SEK -2,128,009 year-over-year.
Result per share for the year was SEK -0.52, down from SEK -0.317 year-over-year.
Equity at period end was SEK 25,722,967, down from SEK 35,497,097.
Cash and cash equivalents at year-end were SEK 843,452, compared to SEK 2,593,629 last year.
Outlook and guidance
No forward-looking guidance or forecasts provided.
Board intends to propose no dividend at the August 2024 AGM.
Latest events from H100 Group
- Strategic shift to Bitcoin treasury drove rapid asset growth but resulted in large non-cash losses.H100
H2 25/2624 Feb 2026 - Scalable health tech platform leverages influencer networks for rapid, recurring global growth.H100
Status Update23 Nov 2025 - Accelerating Bitcoin Treasury and global health initiatives to empower sovereign individuals.H100
Status Update21 Nov 2025 - Strong sales growth and Bitcoin accumulation, but significant non-cash losses and volatility.H100
H1 25/2619 Nov 2025 - Revenue up 166%, net loss reduced, and strategic shift to digital health acquisition underway.H100
H1 24/2513 Jun 2025 - Acquisition-driven transformation and capital infusion position H100 for digital health growth.H100
H2 24/2511 Jun 2025